Table of Contents
| << Previous Issue | Oct 2007 (Vol: 2007, Issue: 88) | Next Issue >> |
- Section: Business Commentaries
-
The CEO's Balancing Act
- Section: Cartoons
-
Nearly
- Section: Deal Trackers
-
Genasense (oblimersen sodium)
- Section: Features
-
POZEN and AstraZeneca Amend Terms of Collaboration for Pain/Inflammation Combination Product
-
Boehringer and Ablynx to Partner Again
-
Delivering Success from Seed Capital Investment
-
Technology Focus: New Frontiers in Transdermal Drug Delivery Systems
- Section: General
-
Partnering between Large Pharmas - Does it Make Sense?
-
Exelixis, Inc.
- Section: Licensing
-
Meda Acquires North Amercian Rights to Potential Blockbuster from BDSI
-
Sepracor’s Insomnia Drug Enters Europe with GSK Deal
-
Novartis Takes option on Radius’ Osteoporosis Drug
- Section: Mergers & Acquisitions
-
Biotest makes Move for US Market
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS